SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-006548
Filing Date
2020-05-14
Accepted
2020-05-14 07:07:45
Documents
42
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mist-20200331x10q.htm 10-Q 1476374
2 EX-31.1 mist-20200331ex3113693d7.htm EX-31.1 13309
3 EX-31.2 mist-20200331ex312b7e718.htm EX-31.2 13301
4 EX-32.1 mist-20200331ex321091966.htm EX-32.1 10719
  Complete submission text file 0001558370-20-006548.txt   3921442

Data Files

Seq Description Document Type Size
5 EX-101.INS mist-20200331.xml EX-101.INS 688537
6 EX-101.SCH mist-20200331.xsd EX-101.SCH 24913
7 EX-101.CAL mist-20200331_cal.xml EX-101.CAL 24602
8 EX-101.DEF mist-20200331_def.xml EX-101.DEF 84868
9 EX-101.LAB mist-20200331_lab.xml EX-101.LAB 234410
10 EX-101.PRE mist-20200331_pre.xml EX-101.PRE 176661
Mailing Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6
Business Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38899 | Film No.: 20875265
SIC: 2834 Pharmaceutical Preparations